One World Products (OWPC) Cash from Investing Activities (2018 - 2023)
One World Products (OWPC) recorded quarterly Cash from Investing Activities of -$5046.0 in Q1 2023, down 179.46% quarter-over-quarter from $6350.0 in Q3 2022, and down 44.92% on a YoY basis from -$9160.7 in Q1 2022.
One World Products (OWPC) Cash from Investing Activities (2018 - 2023) Analysis & Trends
One World Products' Cash from Investing Activities history runs 6 years deep, the most recent figure standing at -$5046.0 for Q1 2023.
- In Q1 2023, Cash from Investing Activities fell 44.92% year-over-year to -$5046.0; the TTM figure through Dec 2023 stood at -$5046.0 (up 86.31% YoY), while the FY2024 annual figure was -$75000.0, down 1386.33% from the prior year.
- Cash from Investing Activities was -$5046.0 for Q1 2023 at One World Products, down from $6350.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $141988.0 in Q3 2019 to a low of -$293259.0 in Q2 2019.
- Historically, Cash from Investing Activities has averaged -$63976.3 across 5 years, with a median of -$39719.0 in 2022.
- The sharpest annual moves came in 2019 and 2021: Cash from Investing Activities surged 147.41% in 2019, then slumped 7039.09% in 2021.
- A 5-year view of Cash from Investing Activities shows it stood at -$242582.0 in 2019, then surged by 89.79% to -$24774.0 in 2020, then sank by 383.48% to -$119778.0 in 2021, then surged by 105.3% to $6350.0 in 2022, then slumped by 179.46% to -$5046.0 in 2023.
- The last three Cash from Investing Activities figures came in at -$5046.0 (Q1 2023), $6350.0 (Q3 2022), and -$39719.0 (Q2 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 229.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -87.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 743.70 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -506.20 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -60.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -2.08 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -15.45 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 25.99 Mn |
| 10 | One World Products | - | - | 48,591.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | -5,046.00 |
| Mar 31, 2023 | -5,046.00 |
| Sep 30, 2022 | 6,350.00 |
| Sep 30, 2022 | 6,350.00 |
| Jun 30, 2022 | -39,719.00 |
| Jun 30, 2022 | -39,719.00 |
| Mar 31, 2022 | -3,482.00 |
| Mar 31, 2022 | -3,482.00 |
| Dec 31, 2021 | -119,778.00 |
| Dec 31, 2021 | -119,778.00 |
| Sep 30, 2021 | -44,301.00 |
| Sep 30, 2021 | -44,301.00 |
| Jun 30, 2021 | -65,934.00 |
| Jun 30, 2021 | -65,934.00 |
| Mar 31, 2021 | -157,988.00 |
| Mar 31, 2021 | -157,988.00 |
| Dec 31, 2020 | -24,774.00 |
| Dec 31, 2020 | -24,774.00 |
| Sep 30, 2020 | -35,580.00 |
| Sep 30, 2020 | -35,580.00 |